Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

In Vitro Longitudinal Relaxivity Profile of Gd(ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent.

Varga-Szemes A, Kiss P, Rab A, Suranyi P, Lenkey Z, Simor T, Bryant RG, Elgavish GA.

PLoS One. 2016 Feb 12;11(2):e0149260. doi: 10.1371/journal.pone.0149260. eCollection 2016.

2.

Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.

Lenkey Z, Varga-Szemes A, Simor T, van der Geest RJ, Kirschner R, Toth L, Bodnar T, Brott BC, Elgavish A, Elgavish GA.

J Magn Reson Imaging. 2016 Apr;43(4):911-20. doi: 10.1002/jmri.25046. Epub 2015 Sep 10.

PMID:
26354594
3.

Infarct density distribution by MRI in the porcine model of acute and chronic myocardial infarction as a potential method transferable to the clinic.

Varga-Szemes A, Simor T, Lenkey Z, van der Geest RJ, Kirschner R, Toth L, Brott BC, Elgavish A, Elgavish GA.

Int J Cardiovasc Imaging. 2014 Jun;30(5):937-48. doi: 10.1007/s10554-014-0408-x. Epub 2014 Apr 10.

4.

Determination of infarct size in ex vivo swine hearts by multidetector computed tomography using gadolinium as contrast medium.

Varga-Szemes A, Ruzsics B, Kirschner R, Singh SP, Kiss P, Brott BC, Simor T, Elgavish A, Elgavish GA.

Invest Radiol. 2012 May;47(5):277-83. doi: 10.1097/RLI.0b013e31823fabc6. Erratum in: Invest Radiol. 2012 Aug;47(8):496.

5.

Embozene™ microspheres induced nonreperfused myocardial infarction in an experimental swine model.

Varga-Szemes A, Kiss P, Brott BC, Wang D, Simor T, Elgavish GA.

Catheter Cardiovasc Interv. 2013 Mar;81(4):689-97. doi: 10.1002/ccd.24418. Epub 2012 May 4.

PMID:
22431438
6.

Quantification of myocardial viability distribution with Gd(DTPA) bolus-enhanced, signal intensity-based percent infarct mapping.

Kirschner R, Varga-Szemes A, Brott BC, Litovsky S, Elgavish A, Elgavish GA, Simor T.

Magn Reson Imaging. 2011 Jun;29(5):650-8. doi: 10.1016/j.mri.2011.02.010. Epub 2011 May 5.

7.

Acute infarct selective MRI contrast agent.

Kirschner R, Varga-Szemes A, Simor T, Suranyi P, Kiss P, Ruzsics B, Brott BC, Elgavish A, Elgavish GA.

Int J Cardiovasc Imaging. 2012 Feb;28(2):285-93. doi: 10.1007/s10554-011-9811-8. Epub 2011 Feb 19.

8.

Percent infarct mapping for delayed contrast enhancement magnetic resonance imaging to quantify myocardial viability by Gd(DTPA).

Simor T, Surányi P, Ruzsics B, Tóth A, Tóth L, Kiss P, Brott BC, Varga-Szemes A, Elgavish A, Elgavish GA.

J Magn Reson Imaging. 2010 Oct;32(4):859-68. doi: 10.1002/jmri.22296.

9.

Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR.

Kirschner R, Toth L, Varga-Szemes A, Simor T, Suranyi P, Kiss P, Ruzsics B, Toth A, Baker R, Brott BC, Litovsky S, Elgavish A, Elgavish GA.

J Cardiovasc Magn Reson. 2010 Apr 7;12:22. doi: 10.1186/1532-429X-12-22.

10.

Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI.

Kiss P, Eltoum IE, Suranyi P, Zeng H, Simor T, Elgavish A, Elgavish GA.

Prostate. 2009 Apr 1;69(5):449-58. doi: 10.1002/pros.20880.

PMID:
19107856
11.

Automated multidetector computed tomography evaluation of subacutely infarcted myocardium.

Ruzsics B, Surányi P, Kiss P, Brott BC, Singh SS, Litovsky S, Aban I, Lloyd SG, Simor T, Elgavish GA, Gupta H.

J Cardiovasc Comput Tomogr. 2008 Jan;2(1):26-32. doi: 10.1016/j.jcct.2007.11.003. Epub 2007 Nov 19.

PMID:
19083913
12.

Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.

Ruzsics B, Surányi P, Kiss P, Brott BC, Elgavish A, Simor T, Elgavish GA.

J Magn Reson Imaging. 2008 Dec;28(6):1386-92. doi: 10.1002/jmri.21571.

PMID:
19025946
13.

Myocardial strain in sub-acute peri-infarct myocardium.

Ruzsics B, Surányi P, Kiss P, Brott BC, Litovsky S, Denney TS Jr, Aban I, Lloyd SG, Simor T, Elgavish GA, Gupta H.

Int J Cardiovasc Imaging. 2009 Feb;25(2):151-9. doi: 10.1007/s10554-008-9364-7. Epub 2008 Oct 15.

PMID:
18855121
14.

In vivo myocardial tissue kinetics of Gd(ABE-DTTA), a tissue-persistent contrast agent.

Surányi P, Kiss P, Ruzsics B, Brott BC, Simor T, Elgavish A, Baker RA, Saab-Ismail NH, Elgavish GA.

Magn Reson Med. 2007 Jul;58(1):55-64.

15.

Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.

Surányi P, Kiss P, Ruzsics B, Brott BC, Simor T, Elgavish GA.

Magn Reson Imaging. 2007 Jun;25(5):641-51. Epub 2006 Nov 21.

PMID:
17540275
16.

A combined method for the determination of myocardial perfusion in experimental animals using microspheres and CMR.

Surányi P, Kiss P, Simor T, Elgavish A, Elgavish GA.

J Cardiovasc Magn Reson. 2007;9(3):549-56.

PMID:
17365234
17.

In vivo R1-enhancement mapping of canine myocardium using ceMRI with Gd(ABE-DTTA) in an acute ischemia-reperfusion model.

Kiss P, Suranyi P, Simor T, Saab-Ismail NH, Elgavish A, Hejjel L, Elgavish GA.

J Magn Reson Imaging. 2006 Sep;24(3):571-9.

PMID:
16892191
18.

Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution.

Surányi P, Kiss P, Brott BC, Simor T, Elgavish A, Ruzsics B, Saab-Ismail NH, Elgavish GA.

Magn Reson Med. 2006 Sep;56(3):535-45.

19.

Gd(ABE-DTTA), a novel contrast agent, at the MRI-effective dose shows absence of deleterious physiological effects in dogs.

Ruzsics B, Surányi P, Kiss P, Brott BC, Elgavish A, Saab-Ismail NH, Simor T, Elgavish GA.

Pharmacology. 2006;77(4):188-94. Epub 2006 Jul 27.

PMID:
16877874
20.

Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart.

Simor T, Gaszner B, Oshinski JN, Waldrop SM, Pettigrew RI, Horváth IG, Hild G, Elgavish GA.

J Magn Reson Imaging. 2005 May;21(5):536-45.

PMID:
15834916
Items per page

Supplemental Content

Loading ...
Write to the Help Desk